Ghent University Hospital
Ghent, 9000, Belgium
Location status: Recruiting
Location contact
Dominic Stoop, Prof. dr.
PRINCIPAL_INVESTIGATOR
Eva Decroos, MD
CONTACT
Kathleen Wijnant, MSc
CONTACT
NCT Number: NCT06952751
Background: Extracellular vesicles (EVs) are membrane-bound vesicles found in all biological fluids, containing various regulatory molecules, including microRNAs (miRNAs). It has been suggested that the EVs in human follicular fluid (the fluid surrounding the oocyte within the ovary) play a crucial role in oocyte development through these miRNAs. However, several methods exist for isolating these EVs from follicular fluid. Before further research can be conducted on the pathophysiology and potential diagnostic and therapeutic applications of these EVs and their content, the optimal isolation technique must be determined for future studies.
Each method has its advantages and disadvantages, and the purity and efficiency may vary between species and different biological fluids. There are only a limited number of studies comparing the various techniques for application in human follicular fluid.
Objective: This study will compare the three most commonly used techniques for isolating EVs: size-based, sedimentation-based (differential ultracentrifugation), and buoyancy-based isolation techniques.
Methodology:
In this prospective study, follicular fluid will be collected from four patients undergoing transvaginal oocyte retrieval following ovarian stimulation at Ghent University Hospital. Patients over 40 years of age or with endometriosis, adenomyosis, or PCOS (polycystic ovarian syndrome) will not be included in this study. During the oocyte retrieval procedure, follicular fluid will be collected from 2-4 oocytes per patient. Since follicular fluid is not used in the patient's treatment (residual material), it does not affect the treatment.
After collection, the three isolation techniques will be applied to each sample. The techniques will be compared in terms of purity (absence of contamination) and efficiency (EV concentration) using transmission electron microscopy, nanoparticle tracking analysis, and proteomic analyses.
Interested in participating?
Request Info18 year–40 year
Female
Interventional
Not applicable
Ghent, 9000, Belgium
Location status: Recruiting
Dominic Stoop, Prof. dr.
PRINCIPAL_INVESTIGATOR
Eva Decroos, MD
CONTACT
Kathleen Wijnant, MSc
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Differential ultracentrifugation
OptiPrep™ density gradient ultracentrifugation
Size-exclusion chromatography
Combined techniques
Time frame: 3 months
Purety of EV isolation
Time frame: 3 months
Efficiency in terms of number of particles
Time frame: 6 months
Efficiency in terms of RIN scoring
Contact information is provided by the study sponsor or research team.
Dominic Stoop, Prof. dr.
CONTACT
Eva Decroos, Dr.
CONTACT
University Hospital, Ghent
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07381933
Extracellular Vesicles, Healthy
Oulu, Finland
View Trial DetailsNCT07273643
Bronchopulmonary Dysplasia, Bronchopulmonary Dysplasia (BPD)
Montpellier, France
View Trial DetailsNCT05625529
Digestive System Diseases, Digestive System Neoplasms
San Diego, California, United States
View Trial DetailsNCT06554951
CAR-T Cell Therapy, Extracellular Vesicles
Bologna, Italy
View Trial Details